These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9798512)

  • 1. Cardioprotective activity of mibefradil.
    van Zwieten PA
    Cardiovasc Res; 1998 Aug; 39(2):276-7. PubMed ID: 9798512
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats.
    Sandmann S; Spitznagel H; Chung O; Xia QG; Illner S; Jänichen G; Rossius B; Daemen MJ; Unger T
    Cardiovasc Res; 1998 Aug; 39(2):339-50. PubMed ID: 9798519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic and therapeutic differences among calcium channel antagonists: profile of mibefradil, a new calcium antagonist.
    Triggle DJ
    Am J Cardiol; 1996 Nov; 78(9A):7-12. PubMed ID: 8903279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short-term treatment of SHR with the novel calcium channel antagonist mibefradil on function of small arteries.
    Li JS; Schiffrin EL
    Am J Hypertens; 1997 Jan; 10(1):94-100. PubMed ID: 9008253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design of the Mortality Assessment in Congestive Heart Failure Trial (MACH-1, mibefradil).
    Levine TB
    Clin Cardiol; 1997 Apr; 20(4):320-6. PubMed ID: 9098588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mibefradil: a new twist to the calcium channel antagonist.
    Lynn MM
    Nurse Pract; 1998 May; 23(5):100, 102-4, 106-7. PubMed ID: 9614683
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure.
    Mulder P; Richard V; Compagnon P; Henry JP; Lallemand F; Clozel JP; Koen R; Macé B; Thuillez C
    J Am Coll Cardiol; 1997 Feb; 29(2):416-21. PubMed ID: 9014998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Introducing mibefradil--a new T-calcium channel blocker].
    Internist (Berl); 1997 Dec; 38(12 Suppl Mibefradil):1-4. PubMed ID: 9437250
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pharmacological and clinical outlook for mibefradil--a new selective T-type calcium channel antagonist].
    Eliseev OM
    Ter Arkh; 1998; 70(8):87-8. PubMed ID: 9841457
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of verapamil and mibefradil on regional blood flow and function in normal and ischemic myocardium.
    Behrends M; Schulz R; Heusch G
    Cardiovasc Drugs Ther; 1999 May; 13(3):275-6. PubMed ID: 10439892
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mibefradil: a new class calcium inhibitor].
    Internist (Berl); 1996 Oct; 37(10 Suppl Mibefradil):1-8. PubMed ID: 9402420
    [No Abstract]   [Full Text] [Related]  

  • 12. Mibefradil release expands calcium-channel-blocker choices.
    Am J Health Syst Pharm; 1997 Sep; 54(18):2033. PubMed ID: 9377200
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mibefradil opens up a new class of calcium antagonists. Glasgow, 23 June 1996].
    Dtsch Med Wochenschr; 1996 Sep; 121(39 Suppl):1-4. PubMed ID: 9212757
    [No Abstract]   [Full Text] [Related]  

  • 14. Mibefradil (posicor).
    Giles TD
    Compr Ther; 1997 Nov; 23(11):761-3. PubMed ID: 9360806
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in new cardiovascular treatment. Background discussion and interview in the Basel Roche Research Center].
    Keil U
    Fortschr Med; 1996 Feb; 114(4):39-40. PubMed ID: 8852686
    [No Abstract]   [Full Text] [Related]  

  • 16. Mibefradil: a selective T-type calcium antagonist.
    Massie BM
    Am J Cardiol; 1997 Nov; 80(9A):23I-32I. PubMed ID: 9375939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of antihypertensive therapy with calcium antagonists: the new molecules].
    Pirrelli A; Vulpis V
    Cardiologia; 1998 Apr; 43(4):357-64. PubMed ID: 9659793
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of calcium antagonists in patients with congestive heart failure.
    Katz S
    Clin Ther; 1997; 19 Suppl A():92-113. PubMed ID: 9385507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic and clinical perspectives on mibefradil: a new T-channel selective calcium antagonist: introduction.
    Giles TD
    Am J Cardiol; 1997 Aug; 80(4B):1C-3C. PubMed ID: 9286847
    [No Abstract]   [Full Text] [Related]  

  • 20. Mibefradil withdrawn from the market.
    Billups SJ; Carter BL
    Ann Pharmacother; 1998; 32(7-8):841. PubMed ID: 9681103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.